Genome-wide and transcriptome-wide association studies of mammographic density phenotypes reveal novel loci
Background: Mammographic density (MD) phenotypes, including percent density (PMD), area of dense tissue (DA), and area of non-dense tissue (NDA), are associated with breast cancer risk. Twin studies suggest that MD phenotypes are highly heritable. However, only a small proportion of their variance i...
| Autores: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Fecha de publicación: | 2022 |
| País: | España |
| Institución: | Instituto de Salud Carlos III (ISCIII) |
| Repositorio: | Repisalud |
| Idioma: | inglés |
| OAI Identifier: | oai:repisalud.isciii.es:20.500.12105/14868 |
| Acceso en línea: | http://hdl.handle.net/20.500.12105/14868 |
| Access Level: | acceso abierto |
| Palabra clave: | Breast Density Breast Neoplasms Female Genetic Predisposition to Disease Genome-Wide Association Study Humans Phenotype Polymorphism, Single Nucleotide Transcriptome |
| id |
ES_ef5f5be7ece5b0e7a1c2ebb44d65c109 |
|---|---|
| oai_identifier_str |
oai:repisalud.isciii.es:20.500.12105/14868 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| dc.title.none.fl_str_mv |
Genome-wide and transcriptome-wide association studies of mammographic density phenotypes reveal novel loci |
| title |
Genome-wide and transcriptome-wide association studies of mammographic density phenotypes reveal novel loci |
| spellingShingle |
Genome-wide and transcriptome-wide association studies of mammographic density phenotypes reveal novel loci Chen, Hongjie Breast Density Breast Neoplasms Female Genetic Predisposition to Disease Genome-Wide Association Study Humans Phenotype Polymorphism, Single Nucleotide Transcriptome |
| title_short |
Genome-wide and transcriptome-wide association studies of mammographic density phenotypes reveal novel loci |
| title_full |
Genome-wide and transcriptome-wide association studies of mammographic density phenotypes reveal novel loci |
| title_fullStr |
Genome-wide and transcriptome-wide association studies of mammographic density phenotypes reveal novel loci |
| title_full_unstemmed |
Genome-wide and transcriptome-wide association studies of mammographic density phenotypes reveal novel loci |
| title_sort |
Genome-wide and transcriptome-wide association studies of mammographic density phenotypes reveal novel loci |
| dc.creator.none.fl_str_mv |
Chen, Hongjie Fan, Shaoqi Stone, Jennifer Thompson, Deborah J Douglas, Julie Li, Shuai Scott, Christopher Bolla, Manjeet K Wang, Qin Dennis, Joe Michailidou, Kyriaki Li, Christopher Peters, Ulrike Hopper, John L Southey, Melissa C Nguyen-Dumont, Tu Nguyen, Tuong L Fasching, Peter A Behrens, Annika Cadby, Gemma Murphy, Rachel A Aronson, Kristan Howell, Anthony Astley, Susan Couch, Fergus Olson, Janet Milne, Roger L Giles, Graham G Haiman, Christopher A Maskarinec, Gertraud Winham, Stacey John, Esther M Kurian, Allison Eliassen, Heather Andrulis, Irene Evans, D Gareth Newman, William G Hall, Per Czene, Kamila Swerdlow, Anthony Jones, Michael Pollan-Santamaria, Marina Fernandez-Navarro, Pablo L McConnell, Daniel S Kristensen, Vessela N Rothstein, Joseph H Wang, Pei Habel, Laurel A Sieh, Weiva Dunning, Alison M Pharoah, Paul D P Easton, Douglas F Gierach, Gretchen L Tamimi, Rulla M Vachon, Celine M Lindström, Sara |
| author |
Chen, Hongjie |
| author_facet |
Chen, Hongjie Fan, Shaoqi Stone, Jennifer Thompson, Deborah J Douglas, Julie Li, Shuai Scott, Christopher Bolla, Manjeet K Wang, Qin Dennis, Joe Michailidou, Kyriaki Li, Christopher Peters, Ulrike Hopper, John L Southey, Melissa C Nguyen-Dumont, Tu Nguyen, Tuong L Fasching, Peter A Behrens, Annika Cadby, Gemma Murphy, Rachel A Aronson, Kristan Howell, Anthony Astley, Susan Couch, Fergus Olson, Janet Milne, Roger L Giles, Graham G Haiman, Christopher A Maskarinec, Gertraud Winham, Stacey John, Esther M Kurian, Allison Eliassen, Heather Andrulis, Irene Evans, D Gareth Newman, William G Hall, Per Czene, Kamila Swerdlow, Anthony Jones, Michael Pollan-Santamaria, Marina Fernandez-Navarro, Pablo L McConnell, Daniel S Kristensen, Vessela N Rothstein, Joseph H Wang, Pei Habel, Laurel A Sieh, Weiva Dunning, Alison M Pharoah, Paul D P Easton, Douglas F Gierach, Gretchen L Tamimi, Rulla M Vachon, Celine M Lindström, Sara |
| author_role |
author |
| author2 |
Fan, Shaoqi Stone, Jennifer Thompson, Deborah J Douglas, Julie Li, Shuai Scott, Christopher Bolla, Manjeet K Wang, Qin Dennis, Joe Michailidou, Kyriaki Li, Christopher Peters, Ulrike Hopper, John L Southey, Melissa C Nguyen-Dumont, Tu Nguyen, Tuong L Fasching, Peter A Behrens, Annika Cadby, Gemma Murphy, Rachel A Aronson, Kristan Howell, Anthony Astley, Susan Couch, Fergus Olson, Janet Milne, Roger L Giles, Graham G Haiman, Christopher A Maskarinec, Gertraud Winham, Stacey John, Esther M Kurian, Allison Eliassen, Heather Andrulis, Irene Evans, D Gareth Newman, William G Hall, Per Czene, Kamila Swerdlow, Anthony Jones, Michael Pollan-Santamaria, Marina Fernandez-Navarro, Pablo L McConnell, Daniel S Kristensen, Vessela N Rothstein, Joseph H Wang, Pei Habel, Laurel A Sieh, Weiva Dunning, Alison M Pharoah, Paul D P Easton, Douglas F Gierach, Gretchen L Tamimi, Rulla M Vachon, Celine M Lindström, Sara |
| author2_role |
author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author |
| dc.contributor.none.fl_str_mv |
Unión Europea. Comisión Europea. H2020 Canadian Institutes of Health Research Quebec Breast Cancer Foundation Government of Quebec (Canadá) National Institutes of Health (Estados Unidos) Unión Europea. Comisión Europea. 7 Programa Marco Cancer Research UK (Reino Unido) Susan G. Komen Breast Cancer Foundation Ovarian Cancer Research Foundation (Astrualia) Australian Breast Cancer Family Study NIH - National Cancer Institute (NCI) (Estados Unidos) National Health and Medical Research Council (Australia) New South Wales Cancer Council (Reino Unido) Victorian Cancer Agency National Breast Cancer Foundation (Australia) Cancer Australia Universitätsklinikum Erlangen (Alemania) Consorcio Gallego de Cáncer de Mama (BREOGAN) Instituto de Salud Carlos III Unión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF) Galicia Sur Biomedical Foundation Xunta de Galicia (España) Ministerio de Sanidad, Servicios Sociales e Igualdad (España) Ministerio de Economía y Competitividad (España) Canadian Cancer Society NIHR - Manchester Biomedical Research Centre (Reino Unido) Cancer Council New South Wales (Australia) Cancer Council Victoria (Australia) Cancer Council Tasmania (Australia) Cancer Council South (Australia) Cancer Council Western Australia (Australia) United States Army Medical Research and Development Command Cancer Council Queensland (Australia) NIH - NCI-Specialized Programs of Research Excellence (SPORE) in Breast Cancer (Estados Unidos) Victorian Health Promotion Foundation The Research Council of Norway (Noruega) Southern and Eastern Norway Regional Health Authority Norwegian Cancer Society Agency for Science, Technology and Research (Singapur) Institute of Cancer Research (Reino Unido) NIHR - Manchester Biomedical Research Centre (Reino Unido) |
| dc.subject.none.fl_str_mv |
Breast Density Breast Neoplasms Female Genetic Predisposition to Disease Genome-Wide Association Study Humans Phenotype Polymorphism, Single Nucleotide Transcriptome |
| topic |
Breast Density Breast Neoplasms Female Genetic Predisposition to Disease Genome-Wide Association Study Humans Phenotype Polymorphism, Single Nucleotide Transcriptome |
| description |
Background: Mammographic density (MD) phenotypes, including percent density (PMD), area of dense tissue (DA), and area of non-dense tissue (NDA), are associated with breast cancer risk. Twin studies suggest that MD phenotypes are highly heritable. However, only a small proportion of their variance is explained by identified genetic variants. Methods: We conducted a genome-wide association study, as well as a transcriptome-wide association study (TWAS), of age- and BMI-adjusted DA, NDA, and PMD in up to 27,900 European-ancestry women from the MODE/BCAC consortia. Results: We identified 28 genome-wide significant loci for MD phenotypes, including nine novel signals (5q11.2, 5q14.1, 5q31.1, 5q33.3, 5q35.1, 7p11.2, 8q24.13, 12p11.2, 16q12.2). Further, 45% of all known breast cancer SNPs were associated with at least one MD phenotype at p < 0.05. TWAS further identified two novel genes (SHOX2 and CRISPLD2) whose genetically predicted expression was significantly associated with MD phenotypes. Conclusions: Our findings provided novel insight into the genetic background of MD phenotypes, and further demonstrated their shared genetic basis with breast cancer. |
| publishDate |
2022 |
| dc.date.none.fl_str_mv |
2022 2022-08-05 2022 2022-04-12 2022 2022-04-12 |
| dc.type.none.fl_str_mv |
journal article http://purl.org/coar/resource_type/c_6501 VoR http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| dc.type.openaire.fl_str_mv |
info:eu-repo/semantics/article |
| format |
article |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/20.500.12105/14868 |
| url |
http://hdl.handle.net/20.500.12105/14868 |
| dc.language.none.fl_str_mv |
Inglés eng |
| language_invalid_str_mv |
Inglés |
| language |
eng |
| dc.relation.none.fl_str_mv |
European Commission http://dx.doi.org/10.13039/501100000780 Horizon 2020 Framework Programme 634935 European Commission http://dx.doi.org/10.13039/501100000780 Horizon 2020 Framework Programme 633784 European Commission http://dx.doi.org/10.13039/501100000780 Seventh Framework Programme 223175 |
| dc.rights.none.fl_str_mv |
open access http://purl.org/coar/access_right/c_abf2 Atribución 4.0 Internacional http://creativecommons.org/licenses/by/4.0/ |
| dc.rights.openaire.fl_str_mv |
info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
open access http://purl.org/coar/access_right/c_abf2 Atribución 4.0 Internacional http://creativecommons.org/licenses/by/4.0/ |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf application/pdf application/vnd.openxmlformats-officedocument.spreadsheetml.sheet |
| dc.publisher.none.fl_str_mv |
BioMed Central (BMC) |
| publisher.none.fl_str_mv |
BioMed Central (BMC) |
| dc.source.none.fl_str_mv |
reponame:Repisalud instname:Instituto de Salud Carlos III (ISCIII) |
| instname_str |
Instituto de Salud Carlos III (ISCIII) |
| reponame_str |
Repisalud |
| collection |
Repisalud |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869423857133158400 |
| spelling |
Genome-wide and transcriptome-wide association studies of mammographic density phenotypes reveal novel lociChen, HongjieFan, ShaoqiStone, JenniferThompson, Deborah JDouglas, JulieLi, ShuaiScott, ChristopherBolla, Manjeet KWang, QinDennis, JoeMichailidou, KyriakiLi, ChristopherPeters, UlrikeHopper, John LSouthey, Melissa CNguyen-Dumont, TuNguyen, Tuong LFasching, Peter ABehrens, AnnikaCadby, GemmaMurphy, Rachel AAronson, KristanHowell, AnthonyAstley, SusanCouch, FergusOlson, JanetMilne, Roger LGiles, Graham GHaiman, Christopher AMaskarinec, GertraudWinham, StaceyJohn, Esther MKurian, AllisonEliassen, HeatherAndrulis, IreneEvans, D GarethNewman, William GHall, PerCzene, KamilaSwerdlow, AnthonyJones, MichaelPollan-Santamaria, MarinaFernandez-Navarro, Pablo LMcConnell, Daniel SKristensen, Vessela NRothstein, Joseph HWang, PeiHabel, Laurel ASieh, WeivaDunning, Alison MPharoah, Paul D PEaston, Douglas FGierach, Gretchen LTamimi, Rulla MVachon, Celine MLindström, SaraBreast DensityBreast NeoplasmsFemaleGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansPhenotypePolymorphism, Single NucleotideTranscriptomeBackground: Mammographic density (MD) phenotypes, including percent density (PMD), area of dense tissue (DA), and area of non-dense tissue (NDA), are associated with breast cancer risk. Twin studies suggest that MD phenotypes are highly heritable. However, only a small proportion of their variance is explained by identified genetic variants. Methods: We conducted a genome-wide association study, as well as a transcriptome-wide association study (TWAS), of age- and BMI-adjusted DA, NDA, and PMD in up to 27,900 European-ancestry women from the MODE/BCAC consortia. Results: We identified 28 genome-wide significant loci for MD phenotypes, including nine novel signals (5q11.2, 5q14.1, 5q31.1, 5q33.3, 5q35.1, 7p11.2, 8q24.13, 12p11.2, 16q12.2). Further, 45% of all known breast cancer SNPs were associated with at least one MD phenotype at p < 0.05. TWAS further identified two novel genes (SHOX2 and CRISPLD2) whose genetically predicted expression was significantly associated with MD phenotypes. Conclusions: Our findings provided novel insight into the genetic background of MD phenotypes, and further demonstrated their shared genetic basis with breast cancer.BioMed Central (BMC)Unión Europea. Comisión Europea. H2020Canadian Institutes of Health ResearchQuebec Breast Cancer FoundationGovernment of Quebec (Canadá)National Institutes of Health (Estados Unidos)Unión Europea. Comisión Europea. 7 Programa MarcoCancer Research UK (Reino Unido)Susan G. Komen Breast Cancer FoundationOvarian Cancer Research Foundation (Astrualia)Australian Breast Cancer Family StudyNIH - National Cancer Institute (NCI) (Estados Unidos)National Health and Medical Research Council (Australia)New South Wales Cancer Council (Reino Unido)Victorian Cancer AgencyNational Breast Cancer Foundation (Australia)Cancer AustraliaUniversitätsklinikum Erlangen (Alemania)Consorcio Gallego de Cáncer de Mama (BREOGAN)Instituto de Salud Carlos IIIUnión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF)Galicia Sur Biomedical FoundationXunta de Galicia (España)Ministerio de Sanidad, Servicios Sociales e Igualdad (España)Ministerio de Economía y Competitividad (España)Canadian Cancer SocietyNIHR - Manchester Biomedical Research Centre (Reino Unido)Cancer Council New South Wales (Australia)Cancer Council Victoria (Australia)Cancer Council Tasmania (Australia)Cancer Council South (Australia)Cancer Council Western Australia (Australia)United States Army Medical Research and Development CommandCancer Council Queensland (Australia)NIH - NCI-Specialized Programs of Research Excellence (SPORE) in Breast Cancer (Estados Unidos)Victorian Health Promotion FoundationThe Research Council of Norway (Noruega)Southern and Eastern Norway Regional Health AuthorityNorwegian Cancer SocietyAgency for Science, Technology and Research (Singapur)Institute of Cancer Research (Reino Unido)NIHR - Manchester Biomedical Research Centre (Reino Unido)20222022-08-0520222022-04-1220222022-04-12journal articlehttp://purl.org/coar/resource_type/c_6501VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfapplication/pdfapplication/vnd.openxmlformats-officedocument.spreadsheetml.sheethttp://hdl.handle.net/20.500.12105/14868reponame:Repisaludinstname:Instituto de Salud Carlos III (ISCIII)InglésengEuropean Commission http://dx.doi.org/10.13039/501100000780 Horizon 2020 Framework Programme 634935European Commission http://dx.doi.org/10.13039/501100000780 Horizon 2020 Framework Programme 633784European Commission http://dx.doi.org/10.13039/501100000780 Seventh Framework Programme 223175open accesshttp://purl.org/coar/access_right/c_abf2Atribución 4.0 Internacionalhttp://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:repisalud.isciii.es:20.500.12105/148682026-06-12T12:43:37Z |
| score |
15,811543 |